Free Trial

Envoy Medical Q3 2023 Earnings Report

Envoy Medical logo
$1.36 -0.03 (-1.81%)
As of 03/28/2025 04:00 PM Eastern

Envoy Medical EPS Results

Actual EPS
$0.13
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Envoy Medical Revenue Results

Actual Revenue
$0.08 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Envoy Medical Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Remove Ads

Envoy Medical Earnings Headlines

Envoy Medical announces four new patents
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Lake Street Sticks to Their Buy Rating for Envoy Medical (COCH)
Envoy Medical reports Q3 EPS (37c) vs. 13c last year.
See More Envoy Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Envoy Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Envoy Medical and other key companies, straight to your email.

About Envoy Medical

Envoy Medical (NASDAQ:COCH), a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

View Envoy Medical Profile

More Earnings Resources from MarketBeat